iGovy › Wegovy side effects › Nausea and vomiting
Wegovy side effects cluster
Wegovy nausea and vomiting: why it happens, what helps and when to worry
Feeling sick is the single most reported Wegovy side effect. In the STEP 1 trial, close to half of people on the 2.4 mg dose reported nausea at some point, against under a fifth on placebo. For most it is worst in the days after a dose step and fades. This guide explains the mechanism, the food and timing changes that make the biggest difference, and the two situations where sickness stops being a side effect to manage and becomes a reason to get help.
Nausea: very commonVomiting: very commonChecked 20 October 2026Author: Nick Johnson
Key facts
- Nausea and vomiting are both in the very common band of the UK leaflet: more than 1 in 10 people.
- In STEP 1, nausea was reported by about 44% of people on Wegovy 2.4 mg and about 17% on placebo; vomiting by about 25% against 7%.
- It peaks after each dose increase and, in the leaflet's words, usually goes away over time.
- Around 4.5% of trial participants stopped Wegovy because of gut side effects, against under 1% on placebo, so it is manageable for the large majority.
- Severe, persistent stomach pain with or without vomiting is the pancreatitis warning sign: stop Wegovy and get urgent help.
- Vomiting that stops you keeping fluids down needs NHS 111 the same day.
Why Wegovy makes you feel sick
Semaglutide copies a gut hormone, GLP-1, that the body releases after a meal. Two of its actions cause nausea. It slows the rate at which the stomach empties, so food sits for longer and a normal-sized meal feels like an oversized one. And it acts on the area of the brainstem that governs appetite, which is also the area that triggers the sensation of nausea. Both effects are strongest when the level of the medicine in your blood jumps, which is exactly what happens in the first week or two after a dose step.
That is why the UK schedule spends four weeks on each of 0.25 mg, 0.5 mg, 1 mg and 1.7 mg before reaching 2.4 mg at week 17. Each step gives the gut time to adapt before the next rise. Nausea that returns for a few days after every increase is expected. Nausea that never settles at a given step is the signal to stay there longer.
A second cause is simply eating less. Long gaps without food, then a large meal, make nausea worse. Dehydration does the same, and because Wegovy also blunts thirst, it is easy to drift into.
How common it is: the trial figures
| STEP 1 (68 weeks, adults without diabetes) | Wegovy 2.4 mg | Placebo |
|---|---|---|
| Nausea | about 44% | about 17% |
| Vomiting | about 25% | about 7% |
| Stopped treatment because of gut side effects | about 4.5% | under 1% |
Most events were mild or moderate and short-lived, clustered around dose escalation. The 7.2 mg dose, licensed for adults with obesity after at least four weeks on 2.4 mg, did not show a markedly different gut side effect pattern from 2.4 mg in its supporting trial, though the leaflet flags other effects (hair loss and skin sensation changes) as more frequent at 7.2 mg.
What helps
Portion size and pace
Eat smaller amounts more often rather than three large meals. Chew slowly and stop before you feel full; with a slower-emptying stomach, fullness arrives late. Many people find plating half their old portion and waiting twenty minutes before deciding on more works better than willpower.
What you eat
Fat and very rich food sit in the stomach longest. Bland, lower fat, cooler foods are usually easier: toast, plain rice, yoghurt, soups, poached eggs, fruit. Greasy, fried and heavily spiced meals are the usual culprits when nausea flares. Strong smells can set it off, so cold food and open windows help some people.
Fluids
Sip through the day rather than drinking a large glass in one go, which fills a slow stomach. If you have been sick, an oral rehydration sachet from the pharmacy replaces the salts water alone does not.
Timing the injection
Some people inject in the evening so the peak of nausea passes overnight. The leaflet allows the injection at any time of day and lets you change your injection day as long as at least three days have passed since the last dose. Ask your prescriber before changing.
Posture and movement
Stay upright for an hour or two after eating; lying down with a full, slow stomach encourages reflux and nausea. Gentle walking after meals helps stomach emptying.
Medicines
A pharmacist or prescriber can advise on anti-sickness medicine if simple measures are not enough. Do not add over the counter remedies on top of each other without asking.
Do not fix it by changing the dose yourself
Splitting, skipping or stretching doses to dodge nausea is not how the medicine is licensed and can leave you at a dose that does not work. The right move is to tell your prescriber; staying an extra four weeks on a step is a normal, licensed option.
When sickness is not just a side effect
A stomach bug can look identical to a side effect. If other people in the household are ill, or the vomiting came on suddenly with diarrhoea and a temperature, treat it as an infection: fluids, rest, and NHS 111 if you cannot keep fluids down. Do not inject your next dose while actively vomiting without checking with your prescriber first.
Should I take the next dose if I still feel sick?
Mild nausea that is easing is not usually a reason to skip. Nausea that is severe, or has not settled at all by the end of the four weeks on a step, is a reason to contact your prescriber before the next scheduled increase. If you have missed a dose, the leaflet's rule is to take it within five days and otherwise skip it and carry on; our missed dose guide walks through it. Never double up.
Frequently asked questions
How long does Wegovy nausea last?
Does nausea mean the medicine is working?
Can I take anti-sickness tablets with Wegovy?
Is vomiting on Wegovy dangerous?
Will nausea come back when I go up to 7.2 mg?
Sources and about this guide
- Wegovy FlexTouch patient information leaflet, revised June 2026 (eMC)
- Wegovy Summary of Product Characteristics, section 4.8 (eMC)
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine 2021; 384: 989-1002.
- NHS: semaglutide
- MHRA Drug Safety Update, January 2026
Written by Nick Johnson, founder of Medstack Ltd and Independent Prescription Pricing Analyst. Checked 20 October 2026 against the June 2026 leaflet. Next review 5 December 2026. iGovy is an independent price comparison site. It does not sell, prescribe or dispense medicines, and this page is general information, not medical advice. No clinician has reviewed it yet. A named reviewer will be added when appointed.
How this guide was checked: every frequency statement was compared line by line with section 4 of the Wegovy FlexTouch patient leaflet revised June 2026 and section 4.8 of the Summary of Product Characteristics on the eMC. Trial figures are quoted from the published STEP papers or the SmPC, never from pharmacy marketing, and NHS pages are used for symptom guidance. The page is re-checked whenever the eMC record changes or the MHRA issues a Drug Safety Update, and at least every three months.
Funding and independence: iGovy earns referral commission when readers use pharmacy discount codes on its price pages. No pharmacy or manufacturer paid for, saw or influenced this guide, and health content is not affected by commercial arrangements. Full policy on the editorial policy page. Corrections via the contact page.
